Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease
about
Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular co-morbidities.Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.
P2860
Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease
@ast
Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease
@en
type
label
Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease
@ast
Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease
@en
prefLabel
Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease
@ast
Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease
@en
P2093
P2860
P1476
Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease
@en
P2093
Brad P Dieter
Celestina Barbosa-Leiker
Ian H de Boer
Katherine R Tuttle
Maryam Afkarian
Radica Z Alicic
Rick L Meek
Robert Short
Sterling M McPherson
P2860
P304
P356
10.1016/J.JDIACOMP.2016.07.018
P577
2016-07-27T00:00:00Z